Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
872
datasets available to search
ShareScore release 0.9.0
Dataset results
872 results for “disease progression”
Open Label Study to Evaluate Efficacy and Long Term Safety of LUM001 (Maralixibat) in the Treatment of Cholestatic Liver Disease in Patients With Progressive Familial Intrahepatic Cholestasis
ClinicalTrials.gov study NCT02057718. IPD Sharing: NO. Countries: 4. Publications: 1.
Prevention of Disease Progression in Early Stage Indolent B Cell Malignancies. (SMM)
ClinicalTrials.gov study NCT00899353. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease
ClinicalTrials.gov study NCT00296374. IPD Sharing: Not stated. Countries: 11. Publications: 2.
A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs)
ClinicalTrials.gov study NCT05321082. IPD Sharing: YES. Countries: 45. Publications: 3.
PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
ClinicalTrials.gov study NCT03132636. IPD Sharing: Not stated. Countries: 10. Publications: 5.
A Study of Pirfenidone in Patients With Unclassifiable Progressive Fibrosing Interstitial Lung Disease
ClinicalTrials.gov study NCT03099187. IPD Sharing: UNDECIDED. Countries: 14. Publications: 5.
Prospective Evaluation of Proteinuria and Renal Function in Non-diabetic Patients With Progressive Renal Disease
ClinicalTrials.gov study NCT00296400. IPD Sharing: Not stated. Countries: 11. Publications: 2.
Therapeutic Nanocatalysis to Slow Disease Progression of Amyotrophic Lateral Sclerosis (ALS)
ClinicalTrials.gov study NCT04098406. IPD Sharing: NO. Countries: 1. Publications: 3.
Study on Disease Progression and Nutritional Status in Bronchiectasis
ClinicalTrials.gov study NCT06344000. IPD Sharing: YES. Countries: 1. Publications: 12.
Senolytic Therapy to Modulate Progression of Alzheimer's Disease
ClinicalTrials.gov study NCT04063124. IPD Sharing: YES. Countries: 1. Publications: 7.
Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes
ClinicalTrials.gov study NCT00116831. IPD Sharing: YES. Countries: 20. Publications: 3.
HALT Progression of Polycystic Kidney Disease Study B
ClinicalTrials.gov study NCT01885559. IPD Sharing: YES. Countries: 1. Publications: 3.
A Study to Compare Disease Progression and Modification Following Treatment With Paliperidone Palmitate Long-Acting Injection or Oral Antipsychotics in Participant's With Recent-onset Schizophrenia or
ClinicalTrials.gov study NCT02431702. IPD Sharing: Not stated. Countries: 3. Publications: 4.
A Study to Assess the Safety, Tolerability, and Effect on Disease Progression of BIIB105 in Participants With Amyotrophic Lateral Sclerosis (ALS) and Participants With the ALS Ataxin-2 (ATXN2) Genetic
ClinicalTrials.gov study NCT04494256. IPD Sharing: YES. Countries: 4. Publications: 1.
Efficacy and Safety of Pembrolizumab (MK-3475) With Lenvatinib (E7080/MK-7902) vs. Docetaxel in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) and Progressive Disease (PD) After Plati
ClinicalTrials.gov study NCT03976375. IPD Sharing: YES. Countries: 18. Publications: 3.
Progress of Mild Alzheimer's Disease in Participants on Solanezumab Versus Placebo
ClinicalTrials.gov study NCT01900665. IPD Sharing: YES. Countries: 11. Publications: 3.
Effect of Statin Therapy on Disease Progression in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
ClinicalTrials.gov study NCT00456365. IPD Sharing: NO. Countries: 1. Publications: 7.
Efficacy and Safety of Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
ClinicalTrials.gov study NCT02999178. IPD Sharing: Not stated. Countries: 15. Publications: 14.
Irinotecan Hydrochloride and Cetuximab With or Without Ramucirumab in Treating Patients With Advanced Colorectal Cancer With Progressive Disease After Treatment With Bevacizumab-Containing Chemotherap
ClinicalTrials.gov study NCT01079780. IPD Sharing: YES. Countries: 1. Publications: 1.
A Follow-up Study Investigating Long Term Treatment With Nintedanib in Patients With Progressive Fibrosing Interstitial Lung Disease (PF-ILD)
ClinicalTrials.gov study NCT03820726. IPD Sharing: YES. Countries: 15. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.